Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease | MicrobiomeTrials← Back to trialsNCT07187466
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-11-09Est. Completion: 2030-03-31
Enrollment target: 146 participants Locations- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States
Other microbiome trials you might be interested in
UrologyUrinary Bladder, OveractiveBenign Prostatic HyperplasiaUrodynamicsHome MonitoringUrinary Incontinence (UI)Lower Urinary Tract Dysfunction
A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and ex…
New Orleans, United StatesEst. completion Jun 2027
Benign Prostatic Hyperplasia
Introduction Men with enlarged prostates commonly experience lower urinary tract symptoms and may go on to develop compl…
Hong Kong, Hong KongCompleted May 17, 2021